Fig. 2From: Optimal surgical treatment for paratesticular leiomyosarcoma: retrospective analysis of 217 reported casesPatients with cutaneous LMS had a slightly better a LR-free survival, b DM-free survival, and c DSS than those with subcutaneous LMS, although the difference was not significant for LR and DSS (p = 0.745, p = 0.033, and p = 0.126, respectively)Back to article page